Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 17:22 (670 d 20:22 ago) – Posting: # 20812
Views: 3,818

» Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.

And all this at the moment is a offense against the law.

Complete thread:

Activity
 Admin contact
21,682 posts in 4,535 threads, 1,541 registered users;
online 12 (0 registered, 12 guests [including 5 identified bots]).
Forum time: Friday 14:44 CEST (Europe/Vienna)

Genius is that which forces
the inertia of humanity to learn.    Henri Bergson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5